New Study : Hepatitis Drugs Could Serve as Coronavirus Treatment

Two hepatitis C (HCV) antiviral drugs were found to raise survival rates for people with moderate or severe COVID-19 according to a series of Iranian studies reported at the online International AIDS Conference last week.

Study co-author Andrew Hill, MD, of Liverpool University said the antiviral drugs sofosbuvir and daclatasvir could offer an affordable and widely accessible treatment option, according to early study findings.

As the global COVID-19 case numbers steadily climb, researchers are testing a plethora of medications used to treat existing conditions as potential treatments for the new coronavirus, now recently coined as SARS-CoV-2.

According to a press release, sofosbuvir and daclatasvir have shown to successfully fight against COVID-19 infection strains. For example, daclatasvir appears to penetrate well into the lungs, which is a major indicator of COVID-19 prevention since it attacks the cardiovascular system.

Findings from the study also pointed to findings from a randomized controlled trial comparing sofosbuvir plus daclatasvir for two weeks versus standard-of-care treatment for adult patients with moderate or severe COVID-19 at four university hospitals in Iran. The study consisted of 66 participants with a fever and restricted breathing who tested positive for SARS-CoV-2 and COVID-19. The patients also reported having diabetes, hypertension, chronic pulmonary disease and obesity, not hepatitis-c.

Researchers reported that 88% of people who took both sofosbuvir and daclatasvir recovered within two weeks. Additionally, 9% versus 21% required mechanical ventilation and three (9%) versus five (15%) patients died.

The study also outlined that sofosbuvir combined with daclatasvir was associated with faster recovery and improved survival. Continued studies will be conducted to crystallize results.

It has been suggested that studies will be expanded to US participants in coming trials.

The study also emphasized that the potential for this treatment to be affordable and globally accessible.

“This treatment is being developed with no support from large pharmaceutical companies, and all our funding is from governments, academia and donor agencies,” Hill said during the convention. “There is already enough generic sofosbuvir and daclatasvir mass produced to treat millions of people if this drug proves effective. We want this treatment to be affordable for anyone with COVID-19 in any country.”

July 22, 2020 by Jasmine Browley

Jasmine Browley

Jasmine Browley holds an MA in journalism from Columbia College Chicago, and has contributed to Ebony, Jet and MADE Magazine among others. So, clearly, she knows some stuff. Follow her digital journey @JasmineBrowley.

Traveling soon? Here’s 5 products to help COVID-proof your plane ride

Whether you’re planning an essential trip or a quick getaway, one thing’s for certain: the traveling process has been forever changed because of the coronavirus. After nearly a year of sheltering in place, people are tending to their cabin fever

What to Expect After Getting The COVID-19 Vaccine

COVID-19 vaccination will help protect you from getting COVID-19. You may have some side effects, which are normal signs that your body is building protection. These side effects may affect your ability to do daily activities, but they should go

Covid-19 Immunity Likely Lasts for Years

While many have raised questions and have concerns about the vaccine, one of the most common questions is will the vaccine be a one-time injection or will it require recurring vaccinations. According to a new study, Covid-19 patients who recovered from

Living with Sickle Cell Disease: Your guide for the COVID-19 Vaccine

As new information surfaces regarding COVID-19 and the COVID-19 Vaccine, many with chronic disease, such as sickle cell disease, question whether or not it is safe for them to get vaccinated. How will my immune system react to it? Is

8 Things Blacks Should Know About COVID-19 Vaccination Program

There are many questions and rumors circulating regarding the novel COVID-19 Vaccine. Our aunties and cousins say one thing and political figures and health officials say another, but here are 8 things you should know about the COVID-19 Vaccine.

This COVID-free Country Could Be first to Be Fully Vaccinated

As countries around the world have started rolling out their vaccination program to provide immunity against the coronavirus disease (Covid-19), the Republic of Palau is poised to become one of the first countries to vaccinate the majority of its population.